- Paper published online October 13, 2026 in Dermatology and Therapy, open access.
- Case report: pediatric patient, genetically confirmed Netherton Syndrome, once-daily QRX003 whole-body application.
Peer-reviewed paper shows pediatric Netherton patient achieved clear skin and no itch after 21 months on QRX003. Phase 2/3 topline data expected Q2 2027.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.